Cargando…
Advanced glycation end products induce brain-derived neurotrophic factor release from human platelets through the Src-family kinase activation
BACKGROUND: Brain-derived neurotrophic factor (BDNF) exerts beneficial effects not only on diabetic neuropathies but also on cardiovascular injury. There is argument regarding the levels of serum BDNF in patients with diabetes mellitus (DM). Because BDNF in peripheral blood is rich in platelets, thi...
Autores principales: | Furukawa, Kazuo, Fuse, Ichiro, Iwakura, Yuriko, Sotoyama, Hidekazu, Hanyu, Osamu, Nawa, Hiroyuki, Sone, Hirohito, Takei, Nobuyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5299653/ https://www.ncbi.nlm.nih.gov/pubmed/28178976 http://dx.doi.org/10.1186/s12933-017-0505-y |
Ejemplares similares
-
A possible link between BDNF and mTOR in control of food intake
por: Takei, Nobuyuki, et al.
Publicado: (2014) -
Neuropathologic Implication of Peripheral Neuregulin-1 and EGF Signals in Dopaminergic Dysfunction and Behavioral Deficits Relevant to Schizophrenia: Their Target Cells and Time Window
por: Nawa, Hiroyuki, et al.
Publicado: (2014) -
Clozapine-dependent inhibition of EGF/neuregulin receptor (ErbB) kinases
por: Kobayashi, Yutaro, et al.
Publicado: (2019) -
Inter‐breeder differences in prepulse inhibition deficits of C57BL/6J mice in a maternal immune activation model
por: Kobayashi, Yutaro, et al.
Publicado: (2021) -
Pallidal Hyperdopaminergic Innervation Underlying D2 Receptor-Dependent Behavioral Deficits in the Schizophrenia Animal Model Established by EGF
por: Sotoyama, Hidekazu, et al.
Publicado: (2011)